Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
Status
Conditions
Treatments
Details and patient eligibility
About
This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis (EoE) and to establish which presenting factors warrant esophageal biopsies. We hypothesize that a greater than expected percentage of patients who are biopsies will have histologic changes consistent with EE.
Full description
All patients presenting with dysphagia who do not already carry a previous diagnosis for their dysphagia will be asked to enroll. If patients have undergone previous work up for dysphagia such as manometry, 24-hour probe, or barium swallow they can still participate in this study. Informed consent will take place prior to enrollment. After patients present with dysphagia they will fill-out a questionnaire regarding their dysphagia symptoms. An EGD with biopsies will then be performed. Biopsies will be taken from 4 quadrants in the proximal and distal esophagus. The distal esophagus biopsies will be taken 5 cm proximal to the Z-line. Proximal biopsies will be taken anywhere proximal to 30 cm from the incisors.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients aged 18-90 presenting with dysphagia or food impaction
- Ability to undergo esophagogastroduodenoscopy and biopsies
- No significant cardiopulmonary disease, or other contraindication to EGD
Exclusion criteria
- Contradiction to EGD and/or biopsies such as Boerhaave's syndrome, or history or bleeding disorder or elevated INR
- Inability to provide informed consent
- Esophageal varices
Trial design
483 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal